Category: MGSG

Following the February meeting of GMMMG, the formulary has been updated to reflect decisions made by the Clinical Reference Group (CRG) and Medicines and Guidelines Subgroup (MGSG). Changes include:

• Addition of NICE guidance and MHRA drug safety updates to formulary
• Duloxetine 90mg and 120mg capsules added to grey list as a GREEN drug
• Insulin degludec added to grey list as a GREEN (specialist initiation) drug
• Isoniazid for tuberculosis prophylaxis in renal patients added to RAG list as GREEN (specialist initiation)
• Dapsone 50mg and 100mg tablets for PCP prophylaxis added to RAG list as GREEN (specialist initiation)

For full details of the changes, please see the Formulary Change Log.

Following the November meeting of GMMMG, the formulary has been updated to reflect decisions made by the Clinical Reference Group (CRG) and Medicines and Guidelines Subgroup (MGSG). Changes include:

• Addition of NICE technology appraisals and MHRA drug safety updates to formulary
• Ustekinumab dose escalation in inflammatory bowel disease commissioning statement updated to include latest evidence

For full details of the changes, please see the Formulary Change Log.